TY  - JOUR
AU  - Gómez Oliver, Francisca
AU  - Fernández de La Rosa, Rubén
AU  - Brackhan, Mirjam
AU  - Bascuñana, Pablo
AU  - Pozo García, Miguel Ángel
AU  - García García, Luis
PY  - 2024
DO  - 10.3390/ijms252312774
SN  - 1422-0067
UR  - https://hdl.handle.net/20.500.14352/111261
T2  - International Journal of Molecular Sciences
AB  - 4-aminopyridine (4-AP) is a non-selective blocker of voltage-dependent K+ channels used to improve walking in multiple sclerosis patients, and it may be useful in the treatment of cerebellar diseases. In animal models, 4-AP is used as a convulsant...
LA  - eng
M2  - 1
PB  - MDPI
KW  - 4-aminopyridine (4-AP)
KW  - seizures
KW  - 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG)
KW  - positron emission tomography (PET)
KW  - hypometabolism
KW  - statistical parametric mapping (SPM)
KW  - hippocampus
KW  - cerebellum
TI  - Seizures Triggered by Systemic Administration of 4-Aminopyridine in Rats Lead to Acute Brain Glucose Hypometabolism, as Assessed by [18F]FDG PET Neuroimaging
TY  - journal article
VL  - 25
ER  -